CryoLife Buy Hold or Sell Recommendation

CRY -- USA Stock  

USD 29.31  0.39  1.35%

Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding CryoLife is 'Strong Buy'. Macroaxis provides CryoLife buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CryoLife positions. The advice algorithm takes into account all of CryoLife available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from CryoLife buy-and-hold prospective. Check also CryoLife Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Execute Advice
Sell CryoLifeBuy CryoLife
Strong Buy

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

For the selected time horizon CryoLife has a risk adjusted performance of 0.1866, jensen alpha of 0.4342, total risk alpha of 0.4619, sortino ratio of 0.2227 and treynor ratio of 2.41
Macroaxis buy, hold, or sell recommendation module can be used to complement current analysts and expert consensus on CryoLife. Our buy, hold, or sell suggestion engine makes use of analyzes the corporation potential to grow using all fundamental data market data available at the time. To make sure CryoLife is not overpriced, please confirm all CryoLife fundamentals including its Book Value Per Share, and the relationship between Net Income and Beta . Given that CryoLife has Number of Shares Shorted of 927.05 K, we suggest you validate CryoLife market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

CryoLife Thematic Classifications

Medical Equipment IdeaMedical Equipment
USA Equities from Medical Equipment industry as classified by Fama & French

CryoLife Returns Distribution Density

Mean Return0.44Value At Risk3.03
Potential Upside5.63Standard Deviation3.04
 Return Density 

CryoLife Greeks

Alpha over DOW
Beta against DOW=0.18
Overall volatility
Information ratio =0.15

CryoLife Volatility Alert

CryoLife has relatively low volatility with skewness of 1.59 and kurtosis of 3.26. However, we advise all investors to independently investigate CryoLife to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.
 Better Than Average     
 Worse Than Average Compare CryoLife to competition

CryoLife Fundamental Vs Peers

FundamentalsCryoLifePeer Average
Return On Equity(2.16) % (15.17) %
Return On Asset1.42 % (15.64) %
Profit Margin(2.34) % (5.50) %
Operating Margin10.85 % (10.91) %
Current Valuation1.41 B152.14 B
Shares Outstanding36.97 M1.43 B
Shares Owned by Insiders7.86 % 6.91 %
Shares Owned by Institutions76.14 % 18.37 %
Number of Shares Shorted927.05 K3.24 M
Price to Earning255.61 times40.69 times
Price to Book4.20 times14.44 times
Price to Sales5.06 times17.81 times
Revenue227.27 M9.85 B
Gross Profit131.34 M21.75 B
EBITDA24.65 M1.41 B
Net Income(5.24 M)517.71 M
Cash and Equivalents24.96 M3.89 B
Cash per Share0.68 times5.17 times
Total Debt218.2 M7.36 B
Debt to Equity80.30 % 0.72 %
Current Ratio4.97 times3.30 times
Book Value Per Share7.39 times13.64 times
Cash Flow from Operations(19.65 M)1.25 B
Short Ratio5.25 times2.09 times
Earnings Per Share0.15 times2.30 times
Price to Earnings To Growth3.29 times1.22 times
Number of Employees1 K10.67 K
Market Capitalization1.15 B29.78 B
Total Asset181.18 M126.86 B
Retained Earnings34.14 M38.24 B
Working Capital90.06 M3.58 B
Current Asset109.66 M36.8 B
   Sale by Lacy Virginia C of 100 shares of CryoLife [view details]

CryoLife Market Momentum

CryoLife Alerts

Trading Alerts and Improvement Suggestions

CryoLife generates negative expected return over the last 30 days
CryoLife has high historical volatility and very poor performance
CryoLife has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial commitments
The company reported last year revenue of 227.27 M. Reported Net Loss for the year was (5.24 M) with profit before taxes, overhead, and interest of 131.34 M.
CRYOLIFE INC has about 24.96 M in cash with (19.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.68.
Over 76.0% of the company shares are held by institutions such as insurance companies
Latest headline from AMS Capital Ltda Buys New Holdings in Cryolife Inc

Latest Analysts View

CryoLife Current Analysts Recommendations

Target Median Price37.50
Target Mean Price36.30
Recommendation Mean1.40
Target High Price38.00
Number Of Analyst Opinions5
Target Low Price32.00
Check also CryoLife Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool. Please also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.